loadpatents
Patent applications and USPTO patent grants for Burns Barbier; Lindsay.The latest application filed is for "inhibiting an immune response mediated by one or more of tlr2, rage, ccr5, cxcr4 and cd4".
Patent | Date |
---|---|
Inhibiting An Immune Response Mediated By One Or More Of Tlr2, Rage, Ccr5, Cxcr4 And Cd4 App 20220233512 - Wang; Hoau-Yan ;   et al. | 2022-07-28 |
Alzheimer's disease assay in a living patient Grant 11,385,221 - Wang , et al. July 12, 2 | 2022-07-12 |
Solid polymorphs of a FLNA-binding compound and its hydrochloride salts Grant 11,370,791 - Zamloot , et al. June 28, 2 | 2022-06-28 |
Alzheimer's Disease Assay in a Living Patient App 20210389298 - Wang; Hoau-Yan ;   et al. | 2021-12-16 |
Method Of Inhibiting Tau Phosphorylation App 20210095248 - Wang; Hoau-Yan ;   et al. | 2021-04-01 |
Method of inhibiting tau phosphorylation Grant 10,760,052 - Wang , et al. Sep | 2020-09-01 |
Solid Polymorphs Of A Flna-binding Compound And Its Hydrochloride Salts App 20200270250 - Zamloot; Michael ;   et al. | 2020-08-27 |
Alzheimer's Disease Assay In A Living Patient App 20190271686 - Wang; Hoau-Yan ;   et al. | 2019-09-05 |
Method for inhibiting growth of cancer cells Grant 10,363,239 - Wang , et al. | 2019-07-30 |
Method Of Inhibiting Tau Phosphorylation App 20190136184 - Wang; Hoau-Yan ;   et al. | 2019-05-09 |
Alzheimer's disease assay in a living patient Grant 10,222,368 - Wang , et al. | 2019-03-05 |
Method For Inhibiting Growth Of Cancer Cells App 20180311210 - Wang; Hoau-Yan ;   et al. | 2018-11-01 |
Method of inhibiting tau phosphorylation Grant 10,017,736 - Wang , et al. July 10, 2 | 2018-07-10 |
Alzheimer's disease assay in a living patient Grant 9,500,640 - Wang , et al. November 22, 2 | 2016-11-22 |
Alzheimer's Disease Assay In A Living Patient App 20160266149 - Wang; Hoau-Yan ;   et al. | 2016-09-15 |
Method for inhibiting growth of cancer cells Grant 9,433,604 - Wang , et al. September 6, 2 | 2016-09-06 |
Filamin A Binding Anti-inflammatory And Analgesic App 20160251374 - Burns Barbier; Lindsay ;   et al. | 2016-09-01 |
Alzheimer's disease assay in a living patient Grant 9,354,223 - Wang , et al. May 31, 2 | 2016-05-31 |
Method For Inhibiting Growth Of Cancer Cells App 20150148318 - Wang; Hoau-Yan ;   et al. | 2015-05-28 |
Filamin A Binding Anti-inflammatory And Analgesic App 20140113895 - Burns Barbier; Lindsay ;   et al. | 2014-04-24 |
Benzazocine-ring Compound Inhibition Of Tau Hyperphosphorylation App 20140094482 - Thornton; George B. ;   et al. | 2014-04-03 |
Alzheimer's Disease Assay In A Living Patient App 20140017698 - WANG; HOAU-YAN ;   et al. | 2014-01-16 |
Alzheimer's Disease Assay In A Living Patient App 20140017699 - Wang; Hoau-Yan ;   et al. | 2014-01-16 |
Method Of Inhibiting Tau Phosphorylation App 20140018341 - Wang; Hoau-Yan ;   et al. | 2014-01-16 |
Filamin A binding anti-inflammatory and analgesic Grant 8,614,324 - Burns Barbier , et al. December 24, 2 | 2013-12-24 |
Analgesia with minimal tolerance and dependence by a mu opioid receptor agonist that also binds filamin A Grant 8,492,349 - Wang , et al. July 23, 2 | 2013-07-23 |
Analgesia With Minimal Tolerance And Dependence By A Mu Opioid Receptor Agonist That Also Binds Filamin A App 20120237951 - Wang; Hoau-Yan ;   et al. | 2012-09-20 |
Filamin A Binding Anti-inflammatory And Analgesic App 20110105481 - Burns Barbier; Lindsay ;   et al. | 2011-05-05 |
Filamin A-binding Anti-inflammatory Analgesic App 20110105484 - Burns Barbier; Lindsay ;   et al. | 2011-05-05 |
Filamin A Binding Anti-inflammatory And Analgesic App 20110105487 - BURNS BARBIER; LINDSAY ;   et al. | 2011-05-05 |
Analgesic That Binds Filamin A App 20100279997 - Burns Barbier; Lindsay ;   et al. | 2010-11-04 |
Novel Analgesic That Binds Filamin A App 20100280057 - Burns Barbier; Lindsay ;   et al. | 2010-11-04 |
Analgesia With Minimal Tolerance And Dependence By A Mu Opioid Receptor Agonist That Also Binds Filamin A App 20090191579 - Wang; Hoau-Yan ;   et al. | 2009-07-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.